These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1263 related articles for article (PubMed ID: 19160234)
1. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Rasmussen MS; Jørgensen LN; Wille-Jørgensen P Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234 [TBL] [Abstract][Full Text] [Related]
2. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777 [TBL] [Abstract][Full Text] [Related]
3. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366 [TBL] [Abstract][Full Text] [Related]
4. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321 [TBL] [Abstract][Full Text] [Related]
5. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Huo MH; Muntz J Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383 [TBL] [Abstract][Full Text] [Related]
6. Pentasaccharides for the prevention of venous thromboembolism. Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Forster R; Stewart M Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384 [TBL] [Abstract][Full Text] [Related]
8. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539 [TBL] [Abstract][Full Text] [Related]
9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for perioperative thromboprophylaxis in people with cancer. Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161 [TBL] [Abstract][Full Text] [Related]
12. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Wille-Jørgensen P; Rasmussen MS; Andersen BR; Borly L Cochrane Database Syst Rev; 2003; (4):CD001217. PubMed ID: 14583929 [TBL] [Abstract][Full Text] [Related]
13. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Di Nisio M; Porreca E; Otten HM; Rutjes AW Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736 [TBL] [Abstract][Full Text] [Related]
14. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity. Herlihy DR; Thomas M; Tran QH; Puttaswamy V Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Robertson L; Strachan J Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640 [TBL] [Abstract][Full Text] [Related]
16. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Di Nisio M; Porreca E; Ferrante N; Otten HM; Cuccurullo F; Rutjes AW Cochrane Database Syst Rev; 2012 Feb; (2):CD008500. PubMed ID: 22336844 [TBL] [Abstract][Full Text] [Related]
17. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Robertson L; Jones LE Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249 [TBL] [Abstract][Full Text] [Related]
18. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Andras A; Sala Tenna A; Stewart M Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834 [TBL] [Abstract][Full Text] [Related]
20. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis. Fagarasanu A; Alotaibi GS; Hrimiuc R; Lee AY; Wu C Ann Surg Oncol; 2016 May; 23(5):1422-30. PubMed ID: 26887853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]